Dissolution of metastatic thymic carcinoma–associated right atrial thrombus with rivaroxaban

Thymic carcinoma typically exhibits more clinically aggressive behavior and portends a worse prognosis as compared to thymoma. Venous thromboembolism is a significant cause of morbidity and mortality in oncologic patients. Traditionally, the standard-of-care management of cancer-associated venous th...

Full description

Saved in:

Bibliographic Details
Published in:	SAGE open medical case reports Vol. 8; p. 2050313X20927596
Main Authors:	Nimblette, Curlene, Seecheran, Rajeev, Kawall, Jessica, Seecheran, Valmiki, Persad, Sangeeta, Ramsaroop, Koomatie, Seecheran, Naveen Anand
Format:	Journal Article
Language:	English
Published:	London, England SAGE Publications 2020 Sage Publications Ltd SAGE Publishing
Subjects:	Blood clots Case Report Case reports Metastasis Thromboembolism rivaroxaban thymoma thrombus Thymic carcinoma direct oral anticoagulation
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Thymic carcinoma typically exhibits more clinically aggressive behavior and portends a worse prognosis as compared to thymoma. Venous thromboembolism is a significant cause of morbidity and mortality in oncologic patients. Traditionally, the standard-of-care management of cancer-associated venous thromboembolism has been therapeutic anticoagulation with low molecular weight heparins; however, with the advent of direct oral anticoagulants, there is an ongoing paradigm shift to transition to these novel agents in an attempt to attenuate cancer-associated venous thromboembolism events. We describe an exceedingly rare case of metastatic thymic carcinoma–associated right atrial thrombus with high-risk embolic features, which subsequently underwent near-complete dissolution with rivaroxaban after 3 months.
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Report-1
ISSN:	2050-313X 2050-313X
DOI:	10.1177/2050313X20927596